The lessons of pharmaceutical history

Coronavirus Daily

Here's the latest news from the global pandemic.

The lessons of pharmaceutical history

The Trump administration has never been secretive about wanting to develop a vaccine quickly. It called its program to develop a shot Operation Warp Speed.

Still, in recent days, some officials have been talking so aggressively about the timeline to get an inoculation to Americans that a reminder about how hard it is to make new treatments and vaccines can be—and how often such efforts fail—feels in order.

U.S. President Donald Trump said it could be "mid-October on" in terms of when U.S. is prepared to distribute a vaccine.

Photographer: Al Drago/Bloomberg

To deploy a vaccine widely by early next year, many things must go right. One of the vaccines has to work. The vaccine that works has to be one of the handful that are already in late-stage trials. There can't be a major safety concern or delay. Clinical trials have to generate strong evidence. The FDA has to accept that evidence and review it rapidly. Manufacturing must go near perfectly. Hundreds of millions of doses must be delivered around the country, likely with some degree of low-temperature storage requirements.

Getting Americans to take it may also be a challenge. For the 2017-2018 flu season, just 37% of Americans got a vaccine, according to the CDC. And the flu vaccine has been around for decades, and not been anywhere near as much of a political lightning rod.

Earlier this month, the National Academies of Sciences, Engineering, and Medicine published a report summarizing expert recommendations for distributing a vaccine. On page 11, it cites a key lesson from past mass vaccination efforts: "Under-promise and over-deliver."

Having violated the first half of that advice, the best hope now is that the U.S. delivers on the second.—Drew Armstrong

Track the virus

Mapping Covid-19 Around the World


What you should read

Stop Working From Home? Never, Some Say
Firms want staff back in office, but employees aren't embracing the idea yet.
MBA Students Seek Post-Pandemic Digital Choice
Business school students want to keep some parts of the virtual classroom.
How Americans Are Moving During Covid-19
Urban exodus? Fewer people moved during the height of the pandemic.
Singapore Faces Construction Woes Amid Virus
Cases at migrant worker dorms cloud the outlook for economic rebound.
China's Dash for PPE Left World Short on Masks
Campaign saved lives, but made foreign governments wary of China reach.

Know someone else who would like this newsletter?  Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.


Popular posts from this blog

Mulan DID NOT make $250 million and the future of film releases

एनसीबी के डिप्टी डायरेक्टर केपीएस मल्होत्रा बोला- मीडिया में झूठी खबर चल रही, हम खंडन जारी कर रहे हैं

'क्रैकडाउन' को लेकर बोले साकिब सलीम- कोरोनाकाल में शूटिंग करने को लेकर पहले थोड़ी हिचकिचाहट थी, हुमा को अबतक इसे देखने का वक्त नहीं मिला